As a pharmaceutical company – headquartered in Zurich – with a long-standing presence in the KSA market, we develop, manufacture and market well-proven and innovative pharmaceuticals in novel drug delivery forms.
Acino KSA is a market leader in advanced drug delivery technologies with a focus on modified release oral forms and oral dispersible forms, for which we also hold patents.
With a clear focus on selected therapeutic areas, Acino KSA is one of the main providers in gastroenterology, pain and cardiovascular markets in both private and governmental sectors.
Our in-depth knowledge of the KSA market that spans over 20 years enables us to adapt to strong, dynamic and ever-changing market needs, however challenging they may be. As we forge new strategic partnerships with leading Saudi-based manufacturers, our company vision aligns with that of the Saudi Vision 2030.
Acino KSA produces and provides high-quality medicines with patients in mind. We are proudly known for the quality of products, people, and service.